Brawn Laboratories Limited Doxycycline Export Data — India (DGFT 2022–2026)

Name: Brawn Laboratories Limited Doxycycline Export Records India — #15 Exporter, 31 Shipments, $951.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Doxycycline

India Pharmaceutical Trade Intelligence

$118.6M408 Suppliers149 CountriesHS 30049099

ExportsIndia → UNITED STATES78.6%India → AUSTRALIA4.0%

ImportsGERMANY → India$382.8K UNITED STATES → India$97.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Brawn Laboratories Limited — Doxycycline Exporter #15 | $951.3K Trade Value | TransData Nexus | TransData Nexus

Brawn Laboratories Limited — Doxycycline Exporter Profile

Indian Pharmaceutical Exporter · #15 for Doxycycline · $951.3K export value · DGFT Verified

Brawn Laboratories Limited is the #15 Indian exporter of Doxycycline with $951.3K in export value and 31 verified shipments. Brawn Laboratories Limited holds a 0.8% market share in Doxycycline exports across 6 countries. The company exports 17 pharmaceutical products worth $22.6M across 10 therapeutic categories.

Brawn Laboratories Limited — Doxycycline Export Profile: Buyers & Destinations

Brawn Laboratories Limited Doxycycline export treemap — buyers and destination countries | TransData Nexus

Where Does Brawn Laboratories Limited Export Doxycycline?

Country	Value	Shipments	Share
VIETNAM, DEMOCRATIC REP. OF	$200.0K	4	38.4%
THAILAND	$111.3K	8	21.4%
VIETNAM	$111.0K	5	21.3%
IRAQ	$50.0K	1	9.6%
ETHIOPIA

Who Are the Top Buyers of Doxycycline from Brawn Laboratories Limited?

Buyer	Country	Value	Orders
MILITARY COMMERICAL JOINT STOCK	VIETNAM, DEMOCRATIC REP. OF	$150.0K	3
GRACE WIN COMPANY LIMITED	THAILAND	$111.3K	8
MILITARY COMMERICAL JOINT STOCK BANK	VIETNAM	$61.0K	4
MILITARY COMMERCIAL JOINT STOCK	VIETNAM, DEMOCRATIC REP. OF	$50.0K	1
ASIA COMMERCIAL BANK	VIETNAM	$50.0K	1
IBN SINA SCIENTIFIC BUREAU AL	IRAQ	$50.0K	1
AWASH BANK S C	ETHIOPIA	$22.9K	1
LABORATORIOS DELTA S.A	CHILE	$9.8K	1
CORPORACION CLEOPHARMA, C.A.	VENEZUELA	$8.1K	7
CORPORACION CLEOPHARMA CA	VENEZUELA	$4.4K	3

Brawn Laboratories Limited supplies Doxycycline to 10 buyers globally. The largest buyer is MILITARY COMMERICAL JOINT STOCK (VIETNAM, DEMOCRATIC REP. OF), followed by GRACE WIN COMPANY LIMITED (THAILAND) and MILITARY COMMERICAL JOINT STOCK BANK (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Doxycycline Formulations Does Brawn Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
DOXYCYCLINE CAPSULES 100MG (HARD GELATINE CAPSULES CONTAINING YELLOW GRANULAR POWDER)NOS	$150.0K	3
DOXYCYCLINE CAPSULES 100MG (HARD GELATINE CAPSULES CONTAINING YELLOW GRANULAR POWDER)NOS	$97.8K	9
DOXYCYCLINE CAPSULES 100MG HARD GELATINE CAPSULES CONTAINING YELLOW GRANULAR POWDER	$67.8K	3
DOXYCYCLINE CAPSULES 100MG (HARD GELATIN	$64.2K	5
DOXYCYCLINE CAPSULES 100MG HARD GELATINE CAPSULES CONTAINING YELLOW GRANULAR POWDER B/NO.BNC0623003BNC0623004*	$50.9K	2
DOXYCYCLINE CAPSULES 100MG HARD GELATINE CAPSULES CONT. YELLOW GRANULAR POWDERBT# BNC0823017-18D/M-08/23D/E-07/26	$50.0K	1
DOXYCYCLINE CAPSULES 100MGHARD GELATINECAPSULE CONTAINING YELLOW GRANULAR POWDER BATCH NO-BNC0923021 D/M-09/2023 D/E-	$22.9K	1
DOXYCYCLINE CAPSULES 100MG HARD GELATINE CAPSULES CONTAINING YELLOW GRANULAR POWDER B/NO.BNC0623004 D/M:02/06/2023**	$10.0K	2
EACH HARD GELATIN CAPSULE CONTAINS : DOXYCYCLINE HYCLATE BP EQ. TO ANHYDROUS DOXYCYCLINE 100 MG	$3.0K	1
EACH HARD GELATIN CAPSULE CONTAINS :DOXYCYCLINE HYCLATE BP EQ TO ANHYDROUS DOXYCYCLINE 100MG	$2.4K	1

Brawn Laboratories Limited exports 11 distinct Doxycycline formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOXYCYCLINE CAPSULES 100MG (HARD GELATINE CAPSULES CONTAININ with 3 shipments worth $150.0K.

How Does Brawn Laboratories Limited Compare to Nearest Doxycycline Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	GLAND PHARMA LTD	$1.1M	23	1	$50.0K
14	MEPRO PHARMACEUTICALS PRIVATE LIMITED	$1.1M	65	3	$16.2K
15	BRAWN LABORATORIES LIMITED ★	$951.3K	31	6	$30.7K
11	ZIM LABORATORIES LIMITED.	$900.0K	18	2	$50.0K
7	CADILA HEALTHCARE LIMITED	$650.0K	13	1	$50.0K

Brawn Laboratories Limited ranks #15 among 408 Indian Doxycycline exporters. Average shipment value of $30.7K compared to the market average of $87.9K. The closest competitors by value are GLAND PHARMA LTD and MEPRO PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Doxycycline Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,633	27.2%
SAHAR AIR	1,215	20.3%
NHAVA SHEVA SEA (INNSA1)	338	5.6%
DELHI AIR CARGO ACC (INDEL4)	336	5.6%
Bombay Air	315	5.3%
DELHI AIR	219	3.7%
JNPT	188	3.1%
JNPT/ NHAVA SHEVA SEA	156	2.6%

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Doxycycline Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Brawn Laboratories. The Israel-Iran tensions have escalated security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, leading to major carriers suspending or restricting transits. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, as reported by industry executives and insurers. (livemint.com)

In the United States, policy shifts towards reshoring pharmaceutical manufacturing and imposing tariffs on imports have prompted Indian companies to invest in U.S. facilities. This strategy aims to mitigate tariff impacts and secure market access. For instance, Indian firms have invested between $500-700 million in U.S. hubs during the partial fiscal year 2025-26, focusing on oncology and biologics. (odrindia.in) Such investments are crucial for maintaining competitiveness in the U.S. market amidst evolving trade policies.

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive. Indian exporters must navigate these regulations to ensure market access, emphasizing the need for robust quality assurance and compliance frameworks. Brawn Laboratories' adherence to these standards is vital for sustaining and expanding its European market presence.

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international quality standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified inspections and enforcement actions, necessitating stringent adherence to Good Manufacturing Practices (GMP). Instances of non-compliance have led to import bans and reputational damage for some Indian firms. (comcec.org) Therefore, Brawn Laboratories must prioritize quality control and regulatory compliance to maintain its export licenses and market credibility.

The Indian government's initiatives to bolster the pharmaceutical sector's compliance infrastructure, including the establishment of a dedicated 'CBAM Facilitation Cell' to assist exporters with complex reporting requirements, reflect a commitment to enhancing global competitiveness. (sgeexport.com) Brawn Laboratories' proactive engagement with these initiatives can further strengthen its compliance posture.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Doxycycline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Brawn Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 31 individual customs records matching Brawn Laboratories Limited exporting Doxycycline, covering 11 formulations to 7 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 149+ countries, 1,051+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Doxycycline

Doxycycline

Brawn Laboratories Limited — Doxycycline Exporter Profile

Brawn Laboratories Limited — Doxycycline Export Profile: Buyers & Destinations

Where Does Brawn Laboratories Limited Export Doxycycline?

Who Are the Top Buyers of Doxycycline from Brawn Laboratories Limited?

What Is India's Total Doxycycline Export Value and How Much Does Brawn Laboratories Limited Contribute?

What Is the Average Shipment Value for Brawn Laboratories Limited's Doxycycline Exports?

How Does Brawn Laboratories Limited Compare to Other Indian Doxycycline Exporters?

What Doxycycline Formulations Does Brawn Laboratories Limited Export?

How Does Brawn Laboratories Limited Compare to Nearest Doxycycline Exporters?

Which Indian Ports Ship Doxycycline Exports?

What Other Antibiotics Products Does Brawn Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Doxycycline Exports

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

About Brawn Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Doxycycline Export Data from Brawn Laboratories Limited

Doxycycline Stats

Company Overview

Top Products by Brawn Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source